NX-1904

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNX-1904
Drug Alias NameNX-1904NX1904
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNextgen Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextgen Bioscience Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A